These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 11808863)

  • 1. Urinary excretion of the 1,4-dihydropyridine calcium antagonist VULM 993 and its metabolites in the rat.
    Stefek M; Faberova V; Musil S; Kakalik I
    Eur J Drug Metab Pharmacokinet; 2001; 26(4):221-6. PubMed ID: 11808863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of a new dihydropyridine calcium antagonist in rats and dogs.
    Takayama F; Iwasawa Y; Saito K; Shiratori K; Ohtawa M
    Xenobiotica; 1989 Dec; 19(12):1407-20. PubMed ID: 2618091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic fate of a new dihydropyridine calcium antagonist, CD-349, in rat and dog.
    Ogawa N; Mizuno K; Fukushima K; Suwa T; Satoh T
    Xenobiotica; 1993 Jul; 23(7):747-59. PubMed ID: 8237057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, distribution, metabolism and excretion of 14C-labelled enantiomers of the calcium channel blocker benidipine after oral administration to rat.
    Kobayashi H; Kobayashi S
    Xenobiotica; 1998 Feb; 28(2):179-97. PubMed ID: 9522442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, metabolism and excretion after oral administration of a new Ca antagonist, 14C-benidipine hydrochloride to man.
    Kobayashi H; Kobayashi S; Dalrymple PD; Wood SG; Chasseaud LF
    Xenobiotica; 1997 Jun; 27(6):597-608. PubMed ID: 9211659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of barnidipine hydrochloride, a potent calcium antagonist, in rat and dog.
    Teramura T; Tokunaga T; Matsumoto H; Watanabe T; Higuchi S
    Xenobiotica; 1996 Feb; 26(2):177-87. PubMed ID: 8868001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrendipine: identification and synthesis of main metabolites.
    Meyer H; Scherling D; Karl W
    Arzneimittelforschung; 1983; 33(11):1528-34. PubMed ID: 6686447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of nicardipine hydrochloride in healthy male volunteers.
    Rush WR; Alexander O; Hall DJ; Cairncross L; Dow RJ; Graham DJ
    Xenobiotica; 1986 Apr; 16(4):341-9. PubMed ID: 3716455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Terashita S; Tokuma Y; Fujiwara T; Shiokawa Y; Okumura K; Noguchi H
    Xenobiotica; 1987 Dec; 17(12):1415-25. PubMed ID: 3439192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Tokuma Y; Fujiwara T; Noguchi H
    Xenobiotica; 1987 Nov; 17(11):1341-9. PubMed ID: 3433803
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.